ULTRAGENYX PHARMACEUTICAL INC. Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests of $7.00 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity
us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests · last filed 2026-08-05
- 2026-06-30: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $7.00M.
- 2026-03-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $7.00M.
- 2025-12-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $7.00M.
- 2025-09-30: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $7.00M.
| Period end | Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests |
|---|---|
| 2026-06-30 | $7.00M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $7.00M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $7.00M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $7.00M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $7.00M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $7.00M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $7.00M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $7.00M 10-Q · filed 2024-11-06 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |